Trial · NCT07905170
Spencer vs Positional Release Techniques for Chronic Subacromial Impingement
NCT07905170, Not applicable, Not yet recruiting, University of Management and Technology Lahore
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Spencer vs Positional Release Techniques for Chronic Subacromial Impingement. Trials, record NCT07905170. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07905170
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Spencer vs Positional Release Techniques for Chronic Subacromial Impingement
- NCT number
- NCT07905170
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 32 participants, estimated
- Lead sponsor
- University of Management and Technology Lahore
- Conditions
- Chronic Subacromial Impingement Syndrome
- Interventions
- spencer technique, positional release technique
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Numerical Pain Rating Scale (NPRS) | Baseline and after 6 weeks | Pain severity will be assessed via the 11-point NPRS (0 = no pain; 10 = maximal pain imaginable) during resting and overhead activities. The NPRS has shown high reliability (ICC = 0.95-0.96) and validity in shoulder pathology. |
| Primary | Joint Position Sense (Proprioception) | Baseline and after 6 weeks | The shoulder joint proprioception will be tested with a Joint Position Sense (JPS) test. The test will be administered in flexed shoulder position (90°), abducted shoulder position (90°) and external rotation position (60°). The patient's arm will be passively positioned to achieve target position and hold it for several seconds for memorization; subsequently, the limb will return to the neutral starting position. Then the patient will be asked to reproduce the target position by moving the arm without vision assistance. |
| Primary | Shoulder Range of Motion - clinometer | Baseline and after 6 weeks | Glenohumeral joint active and passive range of motion, including flexion, abduction, internal rotation, and external rotation, will be assessed using a smartphone-based clinometer application. Smartphone clinometers have been reported as valid and reliable tools for measuring shoulder range of motion, demonstrating excellent intra-rater reliability when compared with the standard universal goniometer |
| Primary | Shoulder Pain and Disability Index (SPADI) | Baseline and after 6 weeks | The SPADI, a 13-question self-administered survey that includes a five-question subscale measuring pain and an eight-question subscale assessing disability, will be used to measure functional disability, rated on a scale of 0 to 10. The total score of SPADI (0-100) is obtained by taking the average of the scores of the two subscales, multiplied by 100. SPADI has been found to have excellent reliability (α = 0.86-0.96; ICC = 0.84-0.95). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07905170
GET https://conductscience.org/api/trials/v1/NCT07905170/registered